L-asparaginase doses number as a prognostic factor in childhood acute lymphoblastic leukemia: A survival analysis study.

We demonstrated that the early interruption of asparaginase treatment could negatively impact the prognosis of patients with ALL, especially HGR, reinforcing the need for careful diagnosis of reactions and the availability of alternative types of asparaginase.